Last reviewed · How we verify
Sodium chloride 0.9% injectable solution — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Sodium chloride 0.9% injectable solution (Sodium chloride 0.9% injectable solution) — Restore Biologics Holdings, Inc. dba Xtressé.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sodium chloride 0.9% injectable solution TARGET | Sodium chloride 0.9% injectable solution | Restore Biologics Holdings, Inc. dba Xtressé | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sodium chloride 0.9% injectable solution CI watch — RSS
- Sodium chloride 0.9% injectable solution CI watch — Atom
- Sodium chloride 0.9% injectable solution CI watch — JSON
- Sodium chloride 0.9% injectable solution alone — RSS
Cite this brief
Drug Landscape (2026). Sodium chloride 0.9% injectable solution — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-chloride-0-9-injectable-solution. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab